The Risperdal Lawsuit
Risperdal is an atypical antipsychotic drug sold by Johnson and Johnson’s pharmaceutical unit, Janssen. It is used to treat schizophrenia, bipolar disorder, and is also used for irritability in children aged 5-16 with autism spectrum disorders. It is also sometimes used for the off-label use of behavioral treatment for ADHD.
The drug is one of Janssen’s best sellers, bringing in as much as over $4.5 billion in sales at its peak in 2007. However, there is a huge problem with the drug.
Some of the boys and men who take Risperdal have developed male breast tissue, a condition known as gynecomastia.
The Risperdal lawsuits are an attempt to seek compensation for the medical harm and losses caused by the Risperdal side effects. People affected will have to undergo medical procedures, even surgery to correct the problems caused by Risperdal. Read more detailed information on the Risperdal lawsuits below.
What is Gynecomastia?
Gynecomastia is the development and enlargement of breast tissues in males.
It can happen on one or both sides or the chest, and may develop evenly or unevenly. It is a major source of distress, pain, and embarrassment for these (often young) men.
Risperdal can cause a number of other side effects and health problems. These side effects can include significant weight gain, and a movement disorder called tardive dyskinesia.
Click here for detailed information on the Risperdal side effects.
So imagine you have a young male child, or a loved one who is taking Risperdal for a certain psychological condition which already causes them a great deal of distress and interferes with their daily functioning. Then, to make things worse, they have been prescribed Risperdal which causes them to develop serious side effects such as serious weight gain and to everyone’s surprise, the development of female-like breasts.
The breasts growth caused by Risperdal gynecomastia is different from normal weight gain; it is the development of actual breast tissue and can even cause nipple lactation.
This can cause extreme stress, embarrassment and social impairment for the individual, who is already likely to be having a hard time because of the psychological issues.
Treatment for gynecomastia typically includes hormonal therapy and/or invasive surgery to remove the breasts.
How does Gynecomastia Happen?
Gynecomastia, or the development of male breast tissue is caused by hormonal imbalance. It is associated with the female hormone prolactin.
Prolactin typically causes the development of breasts in young women, and also triggers lactation (or breast milk) in pregnant women.
However, Risperdal has been shown to cause abnormally high levels of prolactin in men and boys. The elevated levels of prolactin caused by Risperdal can last up to two years after taking the medication, and can cause the development of male breasts and sometimes even nipple secretion.
The Risperdal Lawsuit
Men or boys who have experienced gynecomastia as a result of taking Risperdal may be entitled to file a Risperdal lawsuit. Risperdal lawsuits have already been filed with success against Janssen, and it is anticipated that many more are to follow.
A Risperdal settlement is a monetary award from the court that gives the plaintiff (the individual making the claim of Risperdal injury) compensation for medical bills, pain and suffering, loss of wages, and other damages.
Victims of Risperdal gynecomastia will have to undergo hormonal therapy and likely surgery to remove the breast tissue. It is very unfortunate, risky, painful, and costly.
If you or a loved one have been affected by Risperdal gynecosmastia, we can help. Our experienced Risperdal attorneys are offering a free consultation to determine if you have a viable legal claim.
We do not charge for our legal services unless you collect a settlement.
The consultation is quick and easy, and the process can be started by simply filling out our online claims form, or calling the number below.
Don’t suffer in silence. Contact us at Consumer Claims Center of America to start your Risperdal lawsuit today.